Merging Science with Technology to Treat Disease
Regenerative medicine uses clinical procedures to repair or replace damaged or diseased tissues and organs, versus some traditional therapies that just treat symptoms.
To realize the vast potential of tissue engineering and other techniques aimed at repairing damaged or diseased tissues and organs, the University of Pittsburgh School of Medicine and UPMCestablished the McGowan Institute for Regenerative Medicine. The McGowan Institute serves as a single base of operations for the Universitys leading scientists and clinical faculty working to develop tissue engineering, cellular therapies, and artificial and biohybrid organ devices.
The McGowan Institute is the most ambitious regenerative program in the nation, coupling biology, clinical science, and engineering. Success in our mission will impact patients lives, bring economic benefit, serve to train the next generation of researchers, and advance the expertise of our faculty in the basic sciences, engineering, and clinical sciences. Our efforts proudly build upon the pioneering achievements of the Thomas E. Starzl Transplantation Institute.
While there are certain select therapies based on regenerative medicine principles now in clinical use, much work lies ahead to realize the potential of this growing field. Advances in the underlying science, engineering strategies to harness this science, and successful commercial activities are all required to bring new therapies to patients.
The McGowan Institute sponsors a podcast series on regenerative medicine. Listen to some of the world's leading regenerative medicine researchers and physicians talk about their work.
Listen to the most recent podcasts.
Dr. Steven Little Receives International Young Investigator Award for Development of Novel Drug Delivery Systems
The Controlled Release Society has announced that McGowan Institute for Regenerative Medicine faculty member and University of Pittsburgh professor Steven Little, PhD, is the recipient of its 2018 Young Investigator Award. The honor annually recognizes one individual in the world, 40 years of age or younger, for outstanding contributions in the science of controlled release.
Dr. Stephen Badylak at the World Advanced Therapies & Regenerative Medicine Congress
From Technology Developed at the McGowan Institute, LyGenesis Closes $3 Million Series A Financing to Advance Its Organ Regeneration Technology to the Clinic
Living Donor Liver Transplant: A Lifesaving Option for All Patients with Liver Failure
Recommendation and review posted by G. Smith